drugset / Trial / NCT02549573

Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®

NCT02549573

Phase 4 Terminated 13 enrolled Supernus Pharmaceuticals
RandomizedParallel-groupOpen-labelSupportive care

Summary

To determine if PT intervention will be improved while in the "on" motor state vs. the "end-of-dose-off" motor state during the PT Intervention Visit in subjects with PD.

Timeline

Start
2016-01
Primary completion
2016-12
Completion
2016-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Apomorphine Unknown